Retirement Systems of Alabama Has $17.57 Million Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Retirement Systems of Alabama trimmed its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 0.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 214,603 shares of the company’s stock after selling 1,694 shares during the period. Retirement Systems of Alabama owned about 0.25% of HealthEquity worth $17,565,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in HQY. Wasatch Advisors LP lifted its position in HealthEquity by 6.6% in the 3rd quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company’s stock valued at $635,065,000 after acquiring an additional 483,269 shares in the last quarter. Mackenzie Financial Corp raised its stake in shares of HealthEquity by 16.0% in the 2nd quarter. Mackenzie Financial Corp now owns 2,364,521 shares of the company’s stock valued at $203,822,000 after purchasing an additional 325,906 shares during the period. Generate Investment Management Ltd bought a new stake in shares of HealthEquity in the second quarter valued at about $24,184,000. Vaughan Nelson Investment Management L.P. boosted its position in shares of HealthEquity by 36.7% during the third quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company’s stock worth $69,034,000 after buying an additional 226,563 shares during the period. Finally, Thrivent Financial for Lutherans grew its holdings in shares of HealthEquity by 924.2% during the second quarter. Thrivent Financial for Lutherans now owns 220,220 shares of the company’s stock worth $18,983,000 after buying an additional 198,718 shares in the last quarter. 99.55% of the stock is owned by institutional investors and hedge funds.

HealthEquity Price Performance

Shares of NASDAQ HQY opened at $95.62 on Friday. The company has a quick ratio of 4.10, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The business’s 50 day moving average price is $94.06 and its two-hundred day moving average price is $84.22. The company has a market cap of $8.29 billion, a PE ratio of 87.72, a price-to-earnings-growth ratio of 1.10 and a beta of 0.55. HealthEquity, Inc. has a twelve month low of $62.10 and a twelve month high of $105.82.

Insider Transactions at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of the firm’s stock in a transaction that occurred on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total transaction of $684,585.00. Following the completion of the sale, the director now directly owns 54,719 shares in the company, valued at $4,540,582.62. This trade represents a 13.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Frank Corvino sold 1,247 shares of the company’s stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total value of $100,084.22. Following the completion of the transaction, the director now directly owns 4,823 shares in the company, valued at $387,093.98. The trade was a 20.54 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 43,786 shares of company stock worth $4,140,387. 2.20% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several equities research analysts have commented on HQY shares. JMP Securities boosted their target price on HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research note on Tuesday, December 10th. Barrington Research boosted their price objective on shares of HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research report on Monday, December 2nd. Deutsche Bank Aktiengesellschaft increased their target price on shares of HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. The Goldman Sachs Group began coverage on shares of HealthEquity in a research note on Friday, November 15th. They issued a “neutral” rating and a $108.00 price target on the stock. Finally, Royal Bank of Canada increased their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 10th. One research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $110.71.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.